Press releaseGlobe Newswire
Harvard Apparatus Regenerative Technology
HRGN · OTC
$2.20−$0.014 (−0.63%)TodayMarket closed ·
Prev close $2.21
Latest news
- Press releaseGlobe Newswire
Harvard Apparatus Regenerative Technology Collaborates with University of Southern California to Test Treatment for Esophageal Disease
- Press releaseGlobe Newswire
Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children's Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia
- Press releaseGlobe Newswire
Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
- Press releaseGlobe Newswire
Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.